期刊文献+

腮腺恶性肿瘤术后放射治疗的临床观察

Clinical Observation of Postoperative Radiotherapy with Parotid Gland Tumor Malignant
下载PDF
导出
摘要 目的回顾观察腮腺恶性肿瘤术后放射治疗的作用及影响预后的因素。方法40例经病理证实的腮腺恶性肿瘤(I期7例,Ⅱ期19例,Ⅲ期9例,Ⅳ期5例),术后采用60Coγ线和直线加速器电子束或kv级X线进行放射治疗,并随访满3年。结果全组5年生存率66.8%,5年局控率为77.6%。术后放疗以50~60GY剂量组较好,5年生存率为92.7%。病理类型中腺癌、鳞癌较差。手术后30d内放疗最好,5年生存率87.4%。结论腮腺恶性肿瘤应提倡手术加放疗综合治疗。放疗采用光子束和电子束或kv级X线混合射线照射,肿瘤量以50~60GY为宜。手术后应小于30d放疗,可提高生存率。 Objective To observe the role of postoperative radiotherapy for parotid gland tumor malignant and the prognostic factors retrospectively. Methods In 40 postoperated patients with parotid gland tumor malignant(7 in stage Ⅰ , 19 in stage Ⅱ ,9 in stage Ⅲ1,5 in stage Ⅳ ) were radiated by ^60Co γ-rays and linear accelerater E-rays or kv X-rays. All patients were proved by pathology. Follow-up was over three years. Results The 5-years overall survival rates and local controlrates were 66.8% and 77.6% for all patients,respectively. The group given dose 50 - 60Gy had better prognosis and their 5-years overall survived rates were 92.7%. Poor prognosis was observed in the cases with the pathological dissification of adenocarcinoma, squamous cell carcinoma. The 5-years overall survival rates,in 30day and 〉 30day postoperative radiotherapy were 87.4% and 41.8% for patients,respectively. Conclusion It is recommended that treatment for parotid gland tumor malignant should be combined with surgery and radiation. The patients who were given dose 50 - 60Gy mixed with photon-electron beam can get better prognosis. Radical surgical operation and pathological type are the important prognostic factor. In the group 〈 30day of postoperative radiotherapy can get better prognosis.
出处 《中国现代医生》 2009年第7期51-52,共2页 China Modern Doctor
关键词 腮腺肿瘤/放疗 回顾研究 存活率 预后 Parotid neoplasms/Radiotherapy Retrospective studies Survival rate Prognosis
  • 相关文献

参考文献5

二级参考文献12

  • 1俞志英,许昌韶,姚德元,高耀明,潘行元,惠建华.105例大涎腺恶性肿瘤疗效分析[J].中华放射肿瘤学杂志,1992(3):16-17. 被引量:16
  • 2黎昌学,朱声荣.涎腺多形性腺瘤复发特性的研究进展[J].临床口腔医学杂志,2005,21(2):124-126. 被引量:3
  • 3张杰,张建国,宋铁砾,等.保存面神经治疗腮腺恶性肿瘤[J].中国口腔颌面外科杂志,2005,(3):106-118.
  • 4Storey M R,Garden A S,Morrison W H,et al. Postoperative radiotherapy for malignant tumors of the submandibular gland[J].Int J Radiat Oncol Biol Phys,2001,51(4):952-958.
  • 5North C A,Lee D J,Piantadosi S,et al. Carcinoma of the major salivary glands treated by surgery or surgery plus postoperative radiotherapy[J].Int J Radiat Oncol Biol Phys,1990,18 (6):1319-1326.
  • 6曹子昂 毛君琪 徐瑞祖.国际癌分期标准[M].上海:上海科学技术文献出版社,1994.51-53.
  • 7Garden A S,el-Naggar A K,Morrison W H,et al. Postoperative radio-therapy for malignant tumors of the parotid gland[J].Int J Radiat Oncol Biol Phys,1997,37(1):79-85.
  • 8Renehan A G,Gleave E N,Slevin N J,et al. Clinico-pathological and treatment-related factors influencing survival in parotid cancer[J].Br J Cancer,1999,80(8):1296-1300.
  • 9Carew J F,Spiro R H,Singh B,et al. Treatment of recurrent pleomorphic adenomas of the parotid gland[J].Otolaryngol Head Neck Surg,1999,121(5):539-542.
  • 10高汝贵,田秀春,张春生,陈瑞芬,钟宝民.腮腺恶性肿瘤术后放射治疗意义的探讨[J]天津医药肿瘤学附刊,1982(02).

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部